Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details

Coronavirus Update:What patients and families need to know

Parvathi Mohan, MD

Even before she came to Children’s National as an attending physician in 1988, Parvathi Mohan, MD, knew she wanted to make a difference for pediatric patients with liver disease. Since 1998, Dr. Mohan has grown in her career and embraced her passion for gastroenterology and hepatology, while turning her focus to the study and research of pediatric liver disease.

In her current role, Dr. Mohan focuses on providing treatments for patients who are diagnosed with hepatitis C, hepatitis B, fatty liver, those with advanced liver disease waiting for or have had  a liver transplant, who have loss of intestinal function- short gut syndrome, and other liver diseases that come through the doors at Children’s National.

"You can tell from our meaningful interactions that we all love the children and patients but also care deeply for one another, our peers.”

Throughout her time caregiving and providing treatments for our patients, Dr. Mohan understands how important it is to build a relationship with your patient and his or her family. “Although many of our patients have chronic illness and eventually start to recognize you as their doctor, I always try and make small talk and play with the children to put them at ease before we start getting into determining a diagnosis and initiating treatments.”

One of the best experiences Dr. Mohan has had at Children’s National throughout her career is the sense of family and comradery that runs through the Division of Gastroenterology, Hepatology, and Nutrition medical staff, as well as the patients and their families. “You can tell from our meaningful interactions that we all love the children and parents but also care deeply for one another, our peers.” And it’s this sense of family that provides emotional and physical support when a colleague needs it. “Because of the family-centered environment, support for each other comes very naturally between staff and the children and families we’re caring for.”

“I would love for Children’s National to eventually become a stand-alone liver center.”

In addition to the care she provides as a clinician, Dr. Mohan also is trying to help children overcome liver disease by participating in a groundbreaking, multi-center research study to determine the effects of an FDA-approved drug (currently used only for adults) as treatment for pediatric hepatitis C cases. So far in the study, there have been excellent results for the participants with fewer side effects than previously prescribed drugs. And the study is growing! There are a good number of patients currently participating in this study, but Dr. Mohan is hoping to expand the reach of the study and add more participants to better understand all aspects of the new drug. Although Dr. Mohan couldn’t disclose exact numbers or data due to the ongoing nature of the study, she’s very excited and hopeful about the results and findings this study will bring to the treatment of hepatitis C related liver disease in children.

“I would love for Children’s National to eventually become a stand-alone Liver Center. It would be so important for the gastroenterology team to be recognized for all of the outstanding work that we do. To be known around the country and the world for the work and care we give to patients with liver and other GI diseases is my dream for this organization and the GI team.”

"Stronger is the feeling that you’re supported, helped, and loved."

See more of our Washingtonian Top Doctors